This hub covers pediatric epilepsy in infants, kids, and teens, including diagnosis, syndromes, development, school plans, and safety. New studies translated into clear takeaways for parents.
Usually when two appropriate medications haven’t controlled seizures.
Many families benefit and it depends on seizure frequency, medications, and learning needs.
Often yes, with smart precautions. Ask your neurologist or epileptologist about your child’s specific risks.
Clusters, prolonged seizures, breathing trouble, new weakness, or major regression.
This study looked at whether brain PET scan templates made for children, and matched to different ages, can help improve localization of the epileptogenic zone, the brain area where seizures start, in children with drug-resistant epilepsy.
This paper reviewed published studies on using perampanel alone (monotherapy) in children with epilepsy.
This paper was a systematic review of randomized controlled trials about what to do after the first antiseizure medication (ASM) does not control focal epilepsy.
This study looked at adding ethosuximide, a seizure medicine, to treatment for children with developmental and epileptic encephalopathy with spike-wave activation in sleep (D/EE-SWAS).
This study followed 35 children and adolescents with epilepsy who started levetiracetam, a common seizure medicine.
This article discusses a proposed way to personalize dosing of perampanel, a seizure medicine used in drug-resistant epilepsy.
This study developed and tested a computer model called EffiFormer to detect epileptic seizures from EEG recordings.
Researchers looked at how long it took children with drug-resistant epilepsy to get a presurgical epilepsy evaluation after they were recognized as having drug-resistant epilepsy.
This report describes one infant with global developmental delay and refractory epilepsy associated with a TBC1D24 mutation.